Banxia-Shengjiang drug pair inhibits gastric cancer development and progression by improving body immunity.
Journal Information
Full Title: Medicine (Baltimore)
Abbreviation: Medicine (Baltimore)
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"The authors have no conflicts of interest to disclose."
Funding Disclosure
Evidence found in paper:
"Funding acquisition: Ling Yuan, Yi Nan. This research was funded by Ningxia Natural Science Foundation (No.2023AAC03222), Ningxia Key Research and Development Program (No.2023BEG02015), and National Natural Science Foundation of China (No.82374261)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025